About the Author

I retired from the Wall Street firm, Daiwa Capital Markets America, after holding the positions of Senior Vice President and Director. Daiwa Capital Markets America is a unit of Daiwa Securities Co., Ltd., the second largest investment banking and brokerage firm in Japan and one of the largest worldwide. At Daiwa, I was in charge of research for the U.S. health care market and made investment recommendations regarding pharmaceutical, biotechnology and medical device companies.

Prior to Daiwa, I was Vice President, Corporate Development at Life Technologies, a leading supplier of research products to the biotechnology industry, and Director, Corporate Development at SmithKline Beckman Corporation, a major global supplier of pharmaceuticals and clinical diagnostic products and services. Early in my career at SKB I was a scientist in the organic chemistry section of the Company's pharmaceutical research and development department.

I have a B.S. in chemistry from Villanova University and studied chemistry at the graduate level at Western Reserve University on a National Defense Education Act fellowship. I also completed the Graduate Management Program at the Wharton School of the University of Pennsylvania.

My wife Cathy and I live in Ocean City, NJ. Our son and his wife are the parents of three, two daughters and a son.

Download the report
(1,255 KB, Word doc)